MedTrace Logo

Acromegaly: Patient And Physician Perspectives

NCT03613623 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 152

Last updated 2020-10-28

No results posted yet for this study

Summary

The purpose of the study is to assess the experiences of individuals with acromegaly who are receiving injections as part of their treatment regimen. Another objective of the study is to compare the patients' perception with their doctors' perceptions. The answers are important to help researchers and physicians understand what it is really like to take currently available treatments so that they can make efforts to improve patients' healthcare experiences, reduce treatment burden and, ultimately, improve patient's quality of life.

Conditions

Sponsors & Collaborators

  • Chiasma, Inc.

    collaborator INDUSTRY

  • Tulane University

    lead OTHER

Principal Investigators

  • Lizheng Shi, PhD, MsPharm · Tulane University

Eligibility

Min Age
18 Years
Max Age
94 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-07-02
Primary Completion
2019-12-01
Completion
2020-09-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03613623 on ClinicalTrials.gov